FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: NASDAQ:GERN

Sort
E.g., 2013-05-18
E.g., 2013-05-18
Enter a comma separated list of user names.

Strange Volume of Geron Corporation - NASDAQ:GERN
Posted by akki on November 16th, 2011

Geron Corporation (NASDAQ:GERN) witnessed volume of 9.87 million shares during last trade however it holds an average trading capacity of 1.28 million shares. GERN last trade opened at $1.75 reached intraday low of $1.60 and went -20.45% down to close at $1.75.

Read Full Article and Disclaimer at:http://stockblizzard.com/7458/business-news/strange-volume-of-geron-corp...

Read More
comment 0
Share
Tags:
GERN, Geron, NASDAQ:GERN

GERN, CLNO, LULU, OPXA, - StockHotTips.com Stock Report!
Posted by stocktwit5 on September 18th, 2011

Geron Corporation (Nasdaq:GERN) announced that management will present a company overview upcoming investor conference; UBS Global Life Sciences Conference in New York City. Hoyoung Huh, M.D., Ph.D., Geron's Executive Chairman, and Stephen M. Kelsey, M.D., Executive Vice President, Head of Research & Development and Chief Medical Officer will present at 10:30 a.m.

Read More
comment 0
Share
Tags:
NASDAQ:LULU, Geron, NASDAQ:GERN, Lululemon Athletica, NASDAQ:OPXA, Cleantech Transit, CLNO.OB, Opexa Therapeutics

(GERN, EVCA, BEAT, ORFG, SNBC) Stock Review From PennyOmega.com
Posted by pennylynnomega on February 12th, 2011
Read More
comment 0
Share
Tags:
evca, EVCA.OB, EVCARCO, ORFG.PK, Orofino Gold, gold mining, Eco Friendly, Nasdaq:SNBC, Sun Bancorp, mineral exploration, CardioNet, Geron, NASDAQ:GERN, PINK: ORFG, PINKSHEETS: ORFG, Ary Fernando Pernett Marque, Ning Shi Long, Sur de Bolivar, La Azul La Estrella property, Nasdaq:BEAT

GERN, ONNN, OXGN, DIS, - Geron, ON Semiconductor, Oxigene and Walt Disney Stock Report! From CRWESelect.com
Posted by CRWESelect Stoc... on November 12th, 2010

Geron Corporation (NASDAQ:GERN) previously announced the publication of preclinical data demonstrating that the company’s telomerase inhibitor drug, imetelstat (GRN163L), currently in Phase 2 clinical trials, targets cancer stem cells from multiple myeloma, pancreatic and breast cancers.

Read More
comment 0
Share
Tags:
disney, walt disney, NASDAQ:OXGN, OXiGENE, NASDAQ:ONNN, ON Semiconductor, NYSE:DIS, Geron, NASDAQ:GERN

HIRU, PWRM, GERN, GME, BMJ Stock Market Report from DrStockPick.com
Posted by drstockpick on November 11th, 2010
Read More
comment 0
Share
Tags:
chinese, gamestop, hiru, otc:pwrm, pwrm.ob, nyse:gme, Power3 Medical Products, HIRU.PK, bio tech, Jiangxi Shaungshi Pharmaceuticals, nutritional additives, PINKSHEETS:HIRU, veterinary drugs, AMEX:BMJ, Birks & Mayors, GERN, Geron, NASDAQ:GERN

ADVERTISE WITH US